(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 7.6% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.71%.
Tandem Diabetes Care's revenue in 2025 is $982,951,000.On average, 7 Wall Street analysts forecast TNDM's revenue for 2025 to be $66,970,481,702, with the lowest TNDM revenue forecast at $66,515,954,128, and the highest TNDM revenue forecast at $68,338,993,356. On average, 7 Wall Street analysts forecast TNDM's revenue for 2026 to be $74,237,061,447, with the lowest TNDM revenue forecast at $72,697,102,845, and the highest TNDM revenue forecast at $76,398,465,282.
In 2027, TNDM is forecast to generate $81,582,171,089 in revenue, with the lowest revenue forecast at $79,156,070,218 and the highest revenue forecast at $84,924,187,650.